More
    Guided Solutions - Connecting Talent With Innovation/div>

    Avicenna.ai secures CE marks for two AI fracture detection tools

    French artificial intelligence (AI)-based medical imaging company Avicenna.ai has secured CE marks for a pair of radiologic screening tools to detect fractures from CT...

    Hyperfine wins FDA Clearance for Swoop System with Optive AI

    Hyperfine, the health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—announced FDA...

    BiVacor wins FDA breakthrough nod for Total Artificial Heart

    BiVacor announced it received FDA breakthrough device designation for its Total Artificial Heart (TAH) system. The designation supports the TAH as a bridge to transplant...

    CoreMap wins FDA IDE for ablation mapping tech

    CoreMap received FDA investigational device exemption (IDE) to extend its electrophysiology (EP) mapping trial to the U.S. The study aims to evaluate the safety and...

    Distalmotion wins FDA nod for gallbladder removal with surgical robot

    Distalmotion announced it received FDA 510(k) clearance for the use of its Dexter surgical robot in adult cholecystectomy (gallbladder removal). Lausanne, Switzerland–based Distalmotion already holds...

    Reflow Medical wins De Novo clearance for Spur Retrievable Stent System

    Reflow Medical, Inc., one of the leading developer of innovative medical devices focused on complex cardiovascular disease, announced that the U.S. Food and Drug...

    AnX Robotica wins FDA nod for next-gen gastrointestinal motility capsule

    AnX Robotica announced today that it received FDA 510(k) clearance for its MotiliCap technology with MotiliScan companion software. The company said in a news release...

    Route 92 Medical wins FDA nod for reperfusion system, reports positive study findings

    Route 92 Medical announced its HiPoint Reperfusion System, including the .088in HiPoint 88 aspiration catheter, has shown positive outcomes in the SUMMIT MAX trial...

    Hyalex Orthopaedics’ knee implant trial application gains FDA approval

    Hyalex Orthopaedics’ supplemental investigational device exemption (IDE) application has received approval from the US Food and Drug Administration (FDA) for a clinical trial of...

    Latest articles